Harmony Biosciences Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Harmony Biosciences Hldgs (HRMY).

Price Target Range — 13 Quarters

Analyst Consensus — 13 Analysts

8Buy

3Hold

2Sell

Consensus RatingOutperform# Analysts13Avg. Consensus PT$48Upside to Avg. PT+32.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	Needham	Ami Fadia	Maintained	Buy	$50
Oct 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$55
Oct 12, 2026	Needham	Ami Fadia	Maintained	Buy	$50
Aug 26, 2026	Wolfe Research	Rudy Li	Initiate	Outperform	$60
Aug 5, 2026	Truist Securities	Danielle Brill	PT Raise	Hold	$29→$34
Aug 4, 2026	Needham	Ami Fadia	PT Raise	Buy	$45→$50
Jul 31, 2026	Mizuho	Graig Suvannavejh	PT Raise	Outperform	$50→$51
Jul 16, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$55
Jun 30, 2026	Deutsche Bank	David Hoang	PT Raise	Hold	$30→$36
May 8, 2026	Truist Securities	Danielle Brill	PT Raise	Hold	$25→$29
Feb 25, 2026	UBS	So Youn Shim	PT Cut	Neutral	$46→$36
Feb 25, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$55
Feb 25, 2026	B of A Securities	Jason Gerberry	PT Cut	Underperform	$32→$28
Feb 25, 2026	Needham	Ami Fadia	PT Cut	Buy	$46→$44
Feb 11, 2026	UBS	Ashwani Verma	Downgrade	Buy→Neutral	$43→$46
Jan 8, 2026	Truist Securities	Danielle Brill	PT Cut	Buy	$48→$45
Dec 1, 2025	Mizuho	Graig Suvannavejh	PT Raise	Outperform	$39→$46
Nov 24, 2025	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$55
Nov 24, 2025	Needham	Ami Fadia	Maintained	Buy	$42
Nov 6, 2025	Mizuho	Graig Suvannavejh	PT Raise	Outperform	$36→$39

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

Needham analyst Ami Fadia reiterates Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Buy and maintains $50 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Buy and maintains $55 price target.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

Needham analyst Ami Fadia reiterates Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Buy and maintains $50 price target.

Benzinga Newsdesk

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider ACMR stock: analysts' thoughts

Avi Kapoor

PRO
Wolfe Research Initiates Coverage On Harmony Biosciences Hldgs with Outperform Rating, Announces Price Target of $60

Wolfe Research analyst Rudy Li initiates coverage on Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Outperform rating and announces Price Target of $60.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $34

Truist Securities analyst Danielle Brill maintains Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Hold and raises the price target from $29 to $34.

Benzinga Newsdesk

Harmony Biosciences Holdings Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Harmony Biosciences Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price Target

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
Wolfe Research Initiates Coverage On Harmony Biosciences Hldgs with Outperform Rating, Announces Price Target of $60

PRO
Truist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $34

People Also Watch

People Also Watch

Harmony Biosciences Holdings Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Harmony Biosciences Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRONeedham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

PROHC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price Target

PRONeedham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROWolfe Research Initiates Coverage On Harmony Biosciences Hldgs with Outperform Rating, Announces Price Target of $60

PROTruist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $34

People Also Watch

People Also Watch

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price Target

PRO
Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target

PRO
Wolfe Research Initiates Coverage On Harmony Biosciences Hldgs with Outperform Rating, Announces Price Target of $60

PRO
Truist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $34